enzalutamide
Showing 51 - 75 of 183
Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)
Not yet recruiting
- Prostate Cancer
- +7 more
- NUV-422
- Enzalutamide
- (no location specified)
Jan 12, 2022
Prostate Cancer Trial in Boston (Tivozanib, Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Tivozanib
- Enzalutamide
-
Boston, MassachusettsMassachusetts General Hospital
Oct 25, 2021
Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Abiraterone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 21, 2023
Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)
Completed
- Advanced Epithelial Ovarian
- +3 more
- Enzalutamide
-
Basking Ridge, New Jersey
- +5 more
Mar 4, 2022
Progressive Metastatic Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)
Active, not recruiting
- Progressive Metastatic Prostate Cancer
- Enzalutamide
- Placebo
-
Beijing, China
- +46 more
Jan 13, 2023
Prostatic Tumors, Pelvic Nodal Trial in San Francisco (Enzalutamide, Leuprolide, Intensity-Modulated Radiation Therapy)
Terminated
- Prostatic Neoplasms
- Pelvic Nodal
- Enzalutamide
- +2 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 14, 2021
Metastatic Castration-Resistant Prostate Cancer Trial in Australia (Lu-PSMA, Enzalutamide)
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- Lu-PSMA
- Enzalutamide
-
Camperdown, New South Wales, Australia
- +12 more
Feb 14, 2022
Breast Cancer, Early Stage, Triple Negative Breast Cancer Trial in United States (Enzalutamide, assessment)
Active, not recruiting
- Breast Cancer
- +2 more
- Enzalutamide
- assessment
-
Hartford, Connecticut
- +11 more
Apr 26, 2022
Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer Trial in New Brunswick (drug, other, procedure)
Terminated
- Clear Cell Renal Cell Carcinoma
- Stage I Renal Cell Cancer
- Enzalutamide
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Sep 14, 2021
Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, enzalutamide, abiraterone acetate)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- olaparib
- +3 more
-
Chengdu, China
- +7 more
Aug 5, 2022
Castration-resistant Prostate Cancer Trial in Osaka (Enzalutamide, Flutamide)
Completed
- Castration-resistant Prostate Cancer
- Enzalutamide
- Flutamide
-
Osaka, JapanOsaka City University Graduate School of Medicine
Sep 8, 2021
Adenocarcinoma of the Prostate Trial in United States (Enzalutamide, SRT)
Active, not recruiting
- Adenocarcinoma of the Prostate
- Enzalutamide
- SRT
-
Washington, District of Columbia
- +8 more
Feb 3, 2022
Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,
Active, not recruiting
- Estrogen Receptor Negative
- +6 more
- Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +8 more
Feb 3, 2022
Metastatic Hormone Sensitive Prostate Cancer Treated With
Not yet recruiting
- Metastatic Hormone-sensitive Prostate Cancer
- Apalutamide
- Enzalutamide
-
Innsbruck, Austria
- +42 more
Jun 5, 2023
Metastatic Castration-Resistant Prostate Cancer Trial in United States (ZEN003694, Enzalutamide)
Completed
- Metastatic Castration-Resistant Prostate Cancer
- ZEN003694
- Enzalutamide
-
Los Angeles, California
- +7 more
Nov 2, 2021
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Intermediate Risk Prostate Cancer Trial in Boston (Enzalutamide, External Beam Radiation)
Active, not recruiting
- Intermediate Risk Prostate Cancer
- Enzalutamide
- External Beam Radiation
-
Boston, Massachusetts
- +2 more
Jul 26, 2021
Pancreatic Cancer Trial in Tampa (Enzalutamide, Gemcitabine, Nab-paclitaxel)
Completed
- Pancreatic Cancer
- Enzalutamide
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 16, 2021
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,
Recruiting
- Invasive Breast Carcinoma
- +11 more
- Axillary Lymph Node Dissection
- +5 more
-
Houston, Texas
- +1 more
Mar 10, 2022
Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Enzalutamide, Docetaxel, Prednisolone)
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- Enzalutamide
- +3 more
-
Linz, Austria
- +88 more
Dec 22, 2022
Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)
Recruiting
- Prostate Cancer
- Apalutamide
- Enzalutamide
-
Shatin, Hong KongPrince of Wales Hospital
Aug 3, 2021
Ann Arbor Stage I Mantle Cell Lymphoma, Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma Trial
Terminated
- Ann Arbor Stage I Mantle Cell Lymphoma
- +5 more
- Enzalutamide
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 16, 2021
Prostate Adenocarcinoma Trial in Washington (Entinostat, Enzalutamide)
Terminated
- Prostate Adenocarcinoma
- Entinostat
- Enzalutamide
-
Washington, District of ColumbiaGeorge Washington University - Medical Faculty Associates
Jul 26, 2021